Cancer is the second‐leading cause of death worldwide. Till date, many such effective
treatments are available, for example chemotherapy, surgery, and radiation therapy, but …

Colorectal cancer (CRC) is the second leading cause of cancer death worldwide and mostly
affects men. Around 20% of its incidence is by familiar disposition due to hereditary …

Despite significant advances in treatment modalities over the last decade, neither the
incidence of the disease nor the mortality due to cancer has altered in the last thirty years …

BACKGROUND Because a role for nuclear factor‐κB (NF‐κB) has been implicated in the
pathogenesis of pancreatic carcinoma, this transcription factor is a potential target for the …

The pharmacological propensities of curcumin have been reported in a plethora of pre-
clinical and clinical studies. However, innate attributes account for extremely low oral …

New analogues of curcumin with improved properties are needed to meet therapeutic
requirements. In this study, the effects of C086 on growth inhibition and NFκB pathway …

Curcumin has attracted great attention in the therapeutic arsenal in clinical oncology due to
its chemopreventive, antitumoral, radiosensibilizing and chemosensibilizing activities …

This review chronicles the exploration of the curcumin in terms of development of analogues
for the anticancer activity over the last century. Curcumin is a natural phytochemical …

The most practical approach to reduce the morbidity and mortality of cancer is to delay the
process of carcinogenesis through the use of chemopreventive agents. This necessitates …

Curcumin is a highly pleiotropic molecule found in the rhizomes of Curcuma longa
(turmeric). It is responsible for the yellow color of turmeric and has been shown to inhibit the …